GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Roivant Sciences ROIV · USD

Health Care · US listing · 🇺🇸 United States

Compare

40.67

+4.60%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Roivant Sciences

Our reporting

Next results

9 Nov 2026

Due on 9 Nov 2026. Analysts expect earnings of -0.37 a share on revenue of $4.1m.

Past results

Reported against what analysts expected

6 Aug 202620 May 20266 Feb 202610 Nov 202511 Aug 202510 Feb 2025
Earnings per share-0.33-0.28-0.24-0.20-0.25-0.23
Forecast-0.30-0.29-0.30-0.32-0.25-0.25
Revenue$1.4m$2.5m$2.0m$1.6m$2.2m$9.0m
Forecast$2.1m$3.4m$5.1m$5.6m$7.3m$5.0m

Key events

  1. 1 Oct 20211-to-1 reverse split
  2. 3 Dec 2020Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.